Electronic Journal of General Medicine

• Xie Y, Shi L, He X, Luo Y. Gastrointestinal cancers in China, the USA and Europe. Gastroenterol Rep (Oxf). 2021;9(2):91-104. https://doi.org/10.1093/gastro/goab010 PMid: 34026216 PMCid:PMC8128023
• Gheju A, Jurescu A, Tăban S, Al-Jobory D, Lazăr F, Dema A. Different disease characteristics in young patients with colorectal cancer: A large retrospective study in a city in Romania. J Int Med Res. 2021;49:5. https://doi.org/10.1177/03000605211016630 PMid:34034541 PMCid:PMC8161876
• Valean S, Chira R, Dumitrascu D. Epidemiological trends in digestive cancers in Romania, 1955-2012, compared to alcohol consumption. Correlation or coincidence? Clujul Med. 2018;91(4):376-86. https://doi.org/10.15386/cjmed-1067 PMid:30564012 PMCid:PMC6296719
• Ionescu EM, Tieranu CG, Maftei D. Colorectal cancer trends of 2018 in Romania–An important geographical variation between northern and southern lands and high mortality versus European averages. J Gastrointest Canc. 2021; 52:222-8. https://doi.org/10.1007/s12029-020-00382-3 PMid:32152824
• Chen TM, Huang YT, Wang GC. Outcome of colon cancer initially presenting as colon perforation and obstruction. World J Surg Onc. 2017;15:164. https://doi.org/10.1186/s12957-017-1228-y PMid:28841901 PMCid:PMC5574146
• Schmoll HJ, Van Cutsem E, Stein A, Valentini V, Glimelius B, Haustermans K. ESMO consensus guidelines for management of patients with colon and rectal cancer: A personalized approach to clinical decision making. Ann Oncol Off J Eur Soc Med Oncol. 2012;23:2479-516. https://doi.org/10.1093/annonc/mds236 PMid:23012255
• Benson AB, Venook AP, Bekaii-Saab T, Chan E, Chen YJ, Cooper HS. Colon cancer, version 3.2014. J Natl Compr Cancer Netw. 2014;12:1028-59. https://doi.org/10.6004/jnccn.2014.0099 PMid:24994923
• Otani K, Kawai K, Hata K. Colon cancer with perforation. Surg Today. 2019;49:15-20. https://doi.org/10.1007/s00595-018-1661-8 PMid:29691659
• Tan KK, Hong CC, Zhang J, Liu JZ, Sim R. Predictors of outcome following surgery in colonic perforation: An institution’s experience over 6 years. J Gastrointest Surg. 2011; 15(2):277-84. https://doi.org/10.1007/s11605-010-1330-8 PMid:20824374
• Tan KK, Hong CC, Zhang J, Liu JZ, Sim R. Surgery for perforated colorectal malignancy in an Asian population: An institution’s experience over 5 years. Int J Colorectal Dis. 2010; 25(8):989-95. https://doi.org/10.1007/s00384-010-0945-2 PMid:20390285
• Khan S, Pawlak SE, Eggenberger JC, Lee CS, Szilagy EJ, Margolin DA. Acute colonic perforation associated with colorectal cancer. Am Surg. 2001;67(3):261-4. https://doi.org/10.1177/000313480106700312 PMid:11270886
• Gök MA, Kafadar MT, Yeğen SF. Perforated colorectal cancers: Clinical outcomes of 18 patients who underwent emergency surgery. Prz Gastroenterol. 2021;16(2):161-5. https://doi.org/10.5114/pg.2021.106667 PMid:34276844 PMCid:PMC8275966
• Constantin GB, Firescu D, Voicu D, et al. The influence of the type of surgery on the immediate postoperative results in patients with colorectal cancer operated in emergency. Chirurgia. 2020;115(2):227-35. https://doi.org/10.21614/chirurgia.115.2.227 PMid:32369727
• Medina-Arana V, Martínez-Riera A, Delgado-Plasencia L, et al. Clinicopathological analysis of factors related to colorectal tumor perforation: Influence of angiogenesis. Med (Baltimore). 2015;94(15):e703. https://doi.org/10.1097/MD.0000000000000703 PMid:25881846 PMCid:PMC4602503
• Mihailov R, Firescu D, Constantin GB, et al. Nomogram for prediction of postoperative morbidity in patients with colon cancer requiring emergency therapy. Med Sci Monit. 2022;28:e936303. https://doi.org/10.12659/MSM.936303 PMid:35768977 PMCid:PMC9254725
• Buzia OD, Madalina C, Tatu AL, et al. Stability and microbiological analysis of aloe barbadensis and chamomilla matricaria pharmaceutical forms. Rom J Oral Rehabil. 2022;14(1):216-28.
• Rodríguez-González D, Martínez-Riera A, Delgado-Plasencia L, et al. Lymphs nodes and lymph node ratio as predictive factors of survival in perforated and non-perforated T4 colorectal tumors. J Surg Oncol. 2013;108:176-81. https://doi.org/10.1002/jso.23373 PMid:23832524
• Barbera-Guillem E, Nelson B, Barr B, et al. B lymphocyte pathology in human colorectal cancer. Experimental and clinical therapeutic effects of partial B cell depletion. Cancer Immunol Immunother. 2000;48:541-9. https://doi.org/10.1007/PL00006672 PMid:10630306 PMCid:PMC11037163
• Minhajat R, Mori D, Yamasaki F, et al. Endoglin (CD105) expression in angiogenesis of colon cancer: Analysis using tissue microarrays and comparison with other endothelial markers. Virchows Arch. 2006;448:127-34. https://doi.org/10.1007/s00428-005-0062-8 PMid:16177881
• Markowitz SD, Bertagnolli MM. Molecular basis of colorectal cancer. N Engl J Med. 2009;361:2449-60. https://doi.org/10.1056/NEJMra0804588 PMid:20018966 PMCid:PMC2843693
• Gök MA, Kafadar MT, Yeğen SF. Perforated colorectal cancers: Clinical outcomes of 18 patients who underwent emergency surgery. Prz Gastroenterol. 2021;16(2):161-5. https://doi.org/10.5114/pg.2021.106667 PMid:34276844 PMCid:PMC8275966
• Saha AK, Smith KJ, Sue-Ling H, Sagar PM, Burke D, Finan PJ. Prognostic factors for survival after curative resection of Dukes’ B colonic cancer. Colorectal Dis. 2011;13:1390-4. https://doi.org/10.1111/j.1463-1318.2010.02507.x PMid:21073647
• Constantin GB, Firescu D, Voicu D, et al. The importance of systemic inflammation markers in the survival of patients with complicated colorectal cancer, operated in emergency. Chirurgia. 2020;115(1):39-49. https://doi.org/10.21614/chirurgia.115.1.39 PMid:32155398
• Mihailov R, Firescu D, Voicu D, et al. Challenges and solutions in choosing the surgical treatment in patients with complicated colon cancer operated in an emergency–A retrospective study. Chirurgia. 2021;116(3):312-0. https://doi.org/10.21614/chirurgia.116.3.312 PMid:34191712
• Mihailov R, Firescu D, Constantin GB, et al. Mortality risk stratification in emergency surgery for obstructive colon cancer-external validation of international scores, american college of surgeons national surgical quality improvement program surgical risk calculator (SRC), and the dedicated score of french surgical association (AFC/OCC score). Int J Environ Res Public Health. 2022; 19(20):13513. https://doi.org/10.3390/ijerph192013513 PMid:36294094 PMCid:PMC9603747
• Constantin GB, Firescu D, Mihailov R, et al. A novel clinical nomogram for predicting overall survival in patients with emergency surgery for colorectal cancer. J Pers Med. 2023;13(575):1-17. https://doi.org/10.3390/jpm13040575 PMid:37108961 PMCid:PMC10145637
• Eguchi K, Yao T, Konomoto T, et al. Discordance of P53 mutations of synchronous colorectal carcinomas. Mod Pathol. 2000;13:131-9. https://doi.org/10.1038/modpathol.3880024 PMid:10697269
• Conlin A, Smith G, Carey FA, Wolf CR, Steele RJC. The prognostic significance of K-ras, p53, and APC mutations in colorectal carcinoma. BMJ. 2005;54:1283-6. https://doi.org/10.1136/gut.2005.066514 PMid:15843421 PMCid:PMC1774675
• Da-Zhong C, Xi-Long O, Ting Y. The association of p53 expression levels with clinicopathological features and prognosis of patients with colon cancer following surgery Oncol Lett. 2017;13(5):3538-46. https://doi.org/10.3892/ol.2017.5929 PMid:28521456 PMCid:PMC5431169
• Allegra CJ, Paik S, Colangelo LH, et al. Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with Dukes’ B and C colon cancer: A national cancer institute-national surgical adjuvant breast and bowel project collaborative study. J Clin Oncol. 2003;21:241-50. https://doi.org/10.1200/JCO.2003.05.044 PMid:12525515
• Luțenco V, Rebegea L, Beznea A, et al. Innovative surgical approaches that improve individual outcomes in advanced breast cancer. Int J Womens Health. 2024;16:555-60. https://doi.org/10.2147/IJWH.S447837 PMid:38577150 PMCid:PMC10992669
• Feroz W, Sheikh AMA. Exploring the multiple roles of guardian of the genome: P53. Egypt J Med Hum Genet. 2020;21:49. https://doi.org/10.1186/s43042-020-00089-x
• Hassin O, Oren M. Drugging p53 in cancer: One protein, many targets. Nat Rev Drug Discov. 2023;22:127-44. https://doi.org/10.1038/s41573-022-00571-8 PMid:36216888 PMCid:PMC9549847
• Hu X, Xue Z, He K, et al. Strategies to optimize treatment for locally advanced rectal cancer. Cancers. 2023;15:219. https://doi.org/10.3390/cancers15010219 PMid:36612213 PMCid:PMC9818694
• Liebl MC, Hofmann TG. The role of p53 signaling in colorectal cancer. Cancers. 2021;13:2125. https://doi.org/10.3390/cancers13092125 PMid:33924934 PMCid:PMC8125348
• Kruschewski M, Mueller K, Lipka S, et al. The prognostic impact of p53 expression on sporadic colorectal cancer is dependent on p21 status. Cancers. 2011;3:1274-84. https://doi.org/10.3390/cancers3011274 PMid:24212661 PMCid:PMC3756413
• Wang H. MicroRNAs and apoptosis in colorectal cancer. Int J Mol Sci. 2020;21:5353. https://doi.org/10.3390/ijms21155353 PMid:32731413 PMCid:PMC7432330
• Taha A, Taha-Mehlitz S, Petzold S, et al. Prognostic value of immunohistochemical markers for locally advanced rectal cancer. Molecules. 2022;27:596. https://doi.org/10.3390/molecules27030596 PMid:35163861 PMCid:PMC8839263
• Rahman N, Khan H, Zia A, et al. Bcl-2 modulation in p53 signaling pathway by flavonoids: A potential strategy towards the treatment of cancer. Int J Mol Sci. 2021;22:11315. https://doi.org/10.3390/ijms222111315 PMid:34768743 PMCid:PMC8582810
• Michel M, Kaps L, Maderer A, Galle PR, Moehler M. The role of p53 dysfunction in colorectal cancer and its implication for therapy. Cancers. 2021;13:2296. https://doi.org/10.3390/cancers13102296 PMid:34064974 PMCid:PMC8150459
• Kasurinen JH, Hagström J, Kaprio T, et al. Prognostic values of tissue and serum angiogenic growth factors depend on the phenotypic subtypes of colorectal cancer. Cancers. 2023;15:3871. https://doi.org/10.3390/cancers15153871 PMid:37568687 PMCid:PMC10417397
• Watanabe T, Wu TT, Catalano PJ, et al. Molecular predictors of survival after adjuvant chemotherapy for colon cancer. N Engl J Med. 2001;344:1196-206. https://doi.org/10.1056/NEJM200104193441603 PMid:11309634 PMCid:PMC3584633
• Resnick MB, Routhier J, Konkin T, Sabo E, Pricolo VE. Epidermal growth factor receptor, c-MET, beta-catenin, and p53 expression as prognostic indicators in stage II colon cancer: A tissue microarray study. Clin Cancer Res. 2004;10:3069-75. https://doi.org/10.1158/1078-0432.CCR-03-0462 PMid:15131045
• Nasif WA, El-Emshaty HM, Tabll A, Elmasry SA, Attallah AM, Elhak Gad NA. Immunoreactivity evaluation of mutant p53 gene product with DNA ploidy pattern in colorectal carcinoma. Hepatogastroenterology. 2004;51:1001-6.
• Bouzourene H, Gervaz P, Cerottini JP, et al. p53 and Ki-ras as prognostic factors for Dukes’ stage B colorectal cancer. Eur J Cancer. 2000;36:1008-15. https://doi.org/10.1016/S0959-8049(00)00036-8 PMid:10885605
• Perrone G, Vincenzi B, Santini D, et al. Correlation of p53 and bcl-2 expression with vascular endothelial growth factor (VEGF), microvessel density (MVD) and clinico-pathological features in colon cancer. Cancer Lett. 2004; 208:227-34. https://doi.org/10.1016/j.canlet.2003.11.032 PMid:15142682
• Pu XX, Huang GL, Guo HQ, et al. Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression. J Gastroenterol Hepatol. 2010;25: 1674-80. https://doi.org/10.1111/j.1440-1746.2010.06417.x PMid:20880178
• El-Serafi MM, Bahnassy AA, Ali NM, et al. The prognostic value of c-Kit, K-ras codon 12, and p53 codon 72 mutations in Egyptian patients with stage II colorectal cancer. Cancer. 2010;116:4954-64. https://doi.org/10.1002/cncr.25417 PMid:20652953
• Tocu G, Mihailov R, Serban C, Stefanescu BI, Tutunaru D, Firescu D. The contribution of procalcitonin, C-reactive Protein and Interleukin-6 in the diagnosis and prognosis of surgical sepsis: An observational and statistical study. J Multidiscip Healthc. 2023;16:2351-9. https://doi.org/10.2147/JMDH.S422359 PMid:37601324 PMCid:PMC10439796
• Lan YT, Chang SC, Li AF, et al. p53 protein accumulation as a prognostic marker in sporadic colorectal cancer. Int J Colorectal Dis. 2007;22:499-506. https://doi.org/10.1007/s00384-006-0194-6 PMid:17021749
• Li Y, Wang D, Ge H, Güngör C, Gong X, Chen Y. Cytoskeletal and cytoskeleton-associated proteins: Key regulators of cancer stem cell properties. Pharmaceuticals. 2022;15:1369. https://doi.org/10.3390/ph15111369 PMid:36355541 PMCid:PMC9698833
• Muto S, Enta A, Maruya Y, et al. Wnt/β-catenin signaling and resistance to immune checkpoint inhibitors: From non-small-cell lung cancer to other cancers. Biomedicines. 2023;11:190. https://doi.org/10.3390/biomedicines11010190 PMid:36672698 PMCid:PMC9855612
• Wong SC, Lo ES, Lee KC, Chan JK, Hsiao WL. Prognostic and diagnostic significance of β-catenin nuclear immunostaining in colorectal cancer. Clin Cancer Res. 2004;10:1401-8. https://doi.org/10.1158/1078-0432.CCR-0157-03 PMid:14977843
• Vallée A, Lecarpentier Y, Vallée JN. The key role of the WNT/β-catenin pathway in metabolic reprogramming in cancers under normoxic conditions. Cancers. 2021;13:5557. https://doi.org/10.3390/cancers13215557 PMid:34771718 PMCid:PMC8582658
• Zhu Y, Li X. Advances of Wnt signalling pathway in colorectal cancer. Cells. 2023;12:447. https://doi.org/10.3390/cells12030447 PMid:36766788 PMCid:PMC9913588
• Bhattacharya I, Barman N, Maiti M, Sarkar R. Assessment of beta-catenin expression by immunohistochemistry in colorectal neoplasms and its role as an additional prognostic marker in colorectal adenocarcinoma. Med Pharm Rep. 2019;92(3):246-52. https://doi.org/10.15386/mpr-1218 PMid:31460505 PMCid:PMC6709962
• Kobayashi M, Honma T, Matsuda Y, Suzuki Y. Narisawa R, Ajioka Y. Nuclear translocation of beta-catenin in colorectal cancer. Br J Cancer. 2000;82:1689-93.
• Decuypere JP, Parys JB, Bultynck G. Regulation of the autophagic Bcl-2/beclin 1 interaction. Cells. 2012;1:284-312. https://doi.org/10.3390/cells1030284 PMid:24710477 PMCid:PMC3901098
• Qiu Y, Li P, Ji C. Cell death conversion under hypoxic condition in tumor development and therapy. Int J Mol Sci. 2015;16:25536-51. https://doi.org/10.3390/ijms161025536 PMid:26512660 PMCid:PMC4632814
• Ionescu VA, Gheorghe G, Bacalbasa N, Chiotoroiu AL, Diaconu C. Colorectal cancer: From risk factors to oncogenesis. Medicina. 2023;59:1646. https://doi.org/10.3390/medicina59091646 PMid:37763765 PMCid:PMC10537191
• Kunac N, Filipović N, Kostić S, Vukojević K. The expression pattern of Bcl-2 and Bax in the tumor and stromal cells in colorectal carcinoma. Medicina. 2022;58:1135. https://doi.org/10.3390/medicina58081135 PMid:36013602 PMCid:PMC9416041
• Yang D, He L, Ma S, et al. Pharmacological targeting of Bcl-2 induces caspase 3-mediated cleavage of HDAC6 and regulates the autophagy process in colorectal cancer. Int J Mol Sci. 2023;24:6662. https://doi.org/10.3390/ijms24076662 PMid:37047634 PMCid:PMC10095469
• Singh J, Rajesh NG, Dubashi B, et al. Pattern of expression of CDX2 in colorectal cancer and its role in prognosis: An ambispective observational study. Indian J Med Paediatr Oncol. 2022;11:1750207. https://doi.org/10.1055/s-0042-1750207

Vancouver

Mihailov R, Beznea A, Popazu C, Voicu D, Toma A, Tudorașcu I, et al. The pathological and immunohistochemical profile of tumor angiogenesis in perforated sigmoid carcinoma–Case report and short literature review. ELECTRON J GEN MED. 2024;21(5):em600. https://doi.org/10.29333/ejgm/14847

APA

Mihailov, R., Beznea, A., Popazu, C., Voicu, D., Toma, A., Tudorașcu, I., Rebegea, L., Mihailov, O. M., Lutenco, V., Constantin, G. B., Țocu, G., Niculeț, E., Bîrlă, R., Georgescu, D. E., & Șerban, C. (2024). The pathological and immunohistochemical profile of tumor angiogenesis in perforated sigmoid carcinoma–Case report and short literature review. Electronic Journal of General Medicine, 21(5), em600. https://doi.org/10.29333/ejgm/14847

AMA

Mihailov R, Beznea A, Popazu C, et al. The pathological and immunohistochemical profile of tumor angiogenesis in perforated sigmoid carcinoma–Case report and short literature review. ELECTRON J GEN MED. 2024;21(5), em600. https://doi.org/10.29333/ejgm/14847

Chicago

Mihailov, Raul, Adrian Beznea, Constantin Popazu, Dragoș Voicu, Alexandra Toma, Iulia Tudorașcu, Laura Rebegea, Oana Mariana Mihailov, Valerii Lutenco, Georgiana Bianca Constantin, George Țocu, Elena Niculeț, Rodica Bîrlă, Dragoș Eugen Georgescu, and Cristina Șerban. "The pathological and immunohistochemical profile of tumor angiogenesis in perforated sigmoid carcinoma–Case report and short literature review". Electronic Journal of General Medicine 2024 21 no. 5 (2024): em600. https://doi.org/10.29333/ejgm/14847

Harvard

Mihailov, R., Beznea, A., Popazu, C., Voicu, D., Toma, A., Tudorașcu, I., . . . Șerban, C. (2024). The pathological and immunohistochemical profile of tumor angiogenesis in perforated sigmoid carcinoma–Case report and short literature review. Electronic Journal of General Medicine, 21(5), em600. https://doi.org/10.29333/ejgm/14847

MLA

Mihailov, Raul et al. "The pathological and immunohistochemical profile of tumor angiogenesis in perforated sigmoid carcinoma–Case report and short literature review". Electronic Journal of General Medicine, vol. 21, no. 5, 2024, em600. https://doi.org/10.29333/ejgm/14847